Compare GTBP & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTBP | MTR |
|---|---|---|
| Founded | 1965 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 7.9M |
| IPO Year | N/A | N/A |
| Metric | GTBP | MTR |
|---|---|---|
| Price | $0.71 | $4.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 15.8K |
| Earning Date | 02-20-2026 | 04-02-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $623,288.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.54 | $4.03 |
| 52 Week High | $3.85 | $10.42 |
| Indicator | GTBP | MTR |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 58.02 |
| Support Level | $0.68 | $4.15 |
| Resistance Level | $0.73 | $4.87 |
| Average True Range (ATR) | 0.06 | 0.23 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 42.73 | 73.07 |
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.